FDA Moves to Fast-Track Nicotine Pouch Reviews Under White House Pressure

The U.S. Food and Drug Administration (FDA) is accelerating its review of nicotine pouches, responding to mounting pressure from the White House to clarify the regulatory status of one of the fastest-growing categories in tobacco harm reduction. A Rapidly Expanding Market in Limbo Nicotine pouches, tobacco-free oral sachets delivering nicotine without combustion, have surged in…

FDA Strengthens Packaging Rules for Nicotine Products: Why Child Safety Matters

The U.S. Food and Drug Administration (FDA) has announced strengthened requirements for child-resistant packaging (CRP) on nicotine products, underscoring the critical importance of safeguarding children while balancing access for adult smokers seeking reduced-risk alternatives. The decision comes amid rising concerns about accidental ingestion of nicotine pouches, e-liquids, and other smoke-free products. Although these products pose…

Expert Coalition Voices Alarm Over EU’s Proposed Nicotine Tax Shift

A coalition of 83 distinguished global authorities in public health, nicotine dependence, and tobacco control has issued a forceful open letter to the President of the European Commission and Commissioners. Their unified message: imposing steep new taxes on reduced-risk nicotine alternatives, such as e-cigarettes, heated tobacco, and nicotine pouches, would be a grave misstep. They…

Nicotine Pouches in Saudi Arabia: Early Evidence on Prevalence, Safety, and Smoking Cessation

Nicotine pouches, small tobacco-free sachets delivering nicotine orally, are emerging globally as a potential harm reduction tool. In Saudi Arabia, where smoking remains a major health burden and cultural factors shape patterns of tobacco use, new research provides the first comprehensive look at how nicotine pouches are being adopted, their perceived benefits, and the risks…